Ability of IDO to attenuate liver injury in α-galactosylceramide- induced hepatitis model

Hiroyasu Ito, Masato Hoshi, Hirofumi Ohtaki, Ayako Taguchi, Kazuki Ando, Tetsuya Ishikawa, Yosuke Osawa, Akira Hara, Hisataka Moriwaki, Kuniaki Saito, Mitsuru Seishima

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

IDO converts tryptophan to L-kynurenine, and it is noted as a relevant molecule in promoting tolerance and suppressing adaptive immunity. In this study, we examined the effect of IDO in α-galactosylceramide (α-GalCer)-induced hepatitis. The increase in IDO expression in the liver of wild-type (WT) mice administered α-GalCer was confirmed by real-time PCR, Western blotting, and IDO immunohistochemical analysis. The serum alanine aminotransferase levels in IDO-knockout (KO) mice after α-GalCer injection significantly increased compared with those in WT mice. 1-Methyl-D-tryptophan also exacerbated liver injury in this murine hepatitis model. In α-GalCer-induced hepatitis models, TNF-α is critical in the development of liver injury. The mRNA expression and protein level of TNF-α in the liver from IDO-KO mice were more enhanced compared with those in WT mice. The phenotypes of intrahepatic lymphocytes from WT mice and IDO-KO mice treated with α-GalCer were analyzed by flow cytometry, and the numbers of CD49b+ and CD11b+ cells were found to have increased in IDO-KO mice. Moreover, as a result of the increase in the number of NK cells and macrophages in the liver of IDO-KO mice injected with α-GalCer, TNF-α secretion in these mice was greater than that in WT mice. Deficiency of IDO exacerbated liver injury in α-GalCer-induced hepatitis. IDO induced by proinflammatory cytokines may decrease the number of TNF-α-producing immune cells in the liver. Thus, IDO may suppress overactive immune response in the α-GalCer-induced hepatitis model.

Original languageEnglish
Pages (from-to)4554-4560
Number of pages7
JournalJournal of Immunology
Volume185
Issue number8
DOIs
Publication statusPublished - 15-10-2010
Externally publishedYes

Fingerprint

Galactosylceramides
Hepatitis
Knockout Mice
Liver
Wounds and Injuries
Kynurenine
Adaptive Immunity
Alanine Transaminase
Tryptophan
Natural Killer Cells
Real-Time Polymerase Chain Reaction
Flow Cytometry
Western Blotting
Macrophages
Lymphocytes
Cytokines
Phenotype
Messenger RNA
Injections
Serum

All Science Journal Classification (ASJC) codes

  • Immunology

Cite this

Ito, Hiroyasu ; Hoshi, Masato ; Ohtaki, Hirofumi ; Taguchi, Ayako ; Ando, Kazuki ; Ishikawa, Tetsuya ; Osawa, Yosuke ; Hara, Akira ; Moriwaki, Hisataka ; Saito, Kuniaki ; Seishima, Mitsuru. / Ability of IDO to attenuate liver injury in α-galactosylceramide- induced hepatitis model. In: Journal of Immunology. 2010 ; Vol. 185, No. 8. pp. 4554-4560.
@article{4ca6ef0d77294e419d0ce1911bc86a8f,
title = "Ability of IDO to attenuate liver injury in α-galactosylceramide- induced hepatitis model",
abstract = "IDO converts tryptophan to L-kynurenine, and it is noted as a relevant molecule in promoting tolerance and suppressing adaptive immunity. In this study, we examined the effect of IDO in α-galactosylceramide (α-GalCer)-induced hepatitis. The increase in IDO expression in the liver of wild-type (WT) mice administered α-GalCer was confirmed by real-time PCR, Western blotting, and IDO immunohistochemical analysis. The serum alanine aminotransferase levels in IDO-knockout (KO) mice after α-GalCer injection significantly increased compared with those in WT mice. 1-Methyl-D-tryptophan also exacerbated liver injury in this murine hepatitis model. In α-GalCer-induced hepatitis models, TNF-α is critical in the development of liver injury. The mRNA expression and protein level of TNF-α in the liver from IDO-KO mice were more enhanced compared with those in WT mice. The phenotypes of intrahepatic lymphocytes from WT mice and IDO-KO mice treated with α-GalCer were analyzed by flow cytometry, and the numbers of CD49b+ and CD11b+ cells were found to have increased in IDO-KO mice. Moreover, as a result of the increase in the number of NK cells and macrophages in the liver of IDO-KO mice injected with α-GalCer, TNF-α secretion in these mice was greater than that in WT mice. Deficiency of IDO exacerbated liver injury in α-GalCer-induced hepatitis. IDO induced by proinflammatory cytokines may decrease the number of TNF-α-producing immune cells in the liver. Thus, IDO may suppress overactive immune response in the α-GalCer-induced hepatitis model.",
author = "Hiroyasu Ito and Masato Hoshi and Hirofumi Ohtaki and Ayako Taguchi and Kazuki Ando and Tetsuya Ishikawa and Yosuke Osawa and Akira Hara and Hisataka Moriwaki and Kuniaki Saito and Mitsuru Seishima",
year = "2010",
month = "10",
day = "15",
doi = "10.4049/jimmunol.0904173",
language = "English",
volume = "185",
pages = "4554--4560",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "8",

}

Ito, H, Hoshi, M, Ohtaki, H, Taguchi, A, Ando, K, Ishikawa, T, Osawa, Y, Hara, A, Moriwaki, H, Saito, K & Seishima, M 2010, 'Ability of IDO to attenuate liver injury in α-galactosylceramide- induced hepatitis model', Journal of Immunology, vol. 185, no. 8, pp. 4554-4560. https://doi.org/10.4049/jimmunol.0904173

Ability of IDO to attenuate liver injury in α-galactosylceramide- induced hepatitis model. / Ito, Hiroyasu; Hoshi, Masato; Ohtaki, Hirofumi; Taguchi, Ayako; Ando, Kazuki; Ishikawa, Tetsuya; Osawa, Yosuke; Hara, Akira; Moriwaki, Hisataka; Saito, Kuniaki; Seishima, Mitsuru.

In: Journal of Immunology, Vol. 185, No. 8, 15.10.2010, p. 4554-4560.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Ability of IDO to attenuate liver injury in α-galactosylceramide- induced hepatitis model

AU - Ito, Hiroyasu

AU - Hoshi, Masato

AU - Ohtaki, Hirofumi

AU - Taguchi, Ayako

AU - Ando, Kazuki

AU - Ishikawa, Tetsuya

AU - Osawa, Yosuke

AU - Hara, Akira

AU - Moriwaki, Hisataka

AU - Saito, Kuniaki

AU - Seishima, Mitsuru

PY - 2010/10/15

Y1 - 2010/10/15

N2 - IDO converts tryptophan to L-kynurenine, and it is noted as a relevant molecule in promoting tolerance and suppressing adaptive immunity. In this study, we examined the effect of IDO in α-galactosylceramide (α-GalCer)-induced hepatitis. The increase in IDO expression in the liver of wild-type (WT) mice administered α-GalCer was confirmed by real-time PCR, Western blotting, and IDO immunohistochemical analysis. The serum alanine aminotransferase levels in IDO-knockout (KO) mice after α-GalCer injection significantly increased compared with those in WT mice. 1-Methyl-D-tryptophan also exacerbated liver injury in this murine hepatitis model. In α-GalCer-induced hepatitis models, TNF-α is critical in the development of liver injury. The mRNA expression and protein level of TNF-α in the liver from IDO-KO mice were more enhanced compared with those in WT mice. The phenotypes of intrahepatic lymphocytes from WT mice and IDO-KO mice treated with α-GalCer were analyzed by flow cytometry, and the numbers of CD49b+ and CD11b+ cells were found to have increased in IDO-KO mice. Moreover, as a result of the increase in the number of NK cells and macrophages in the liver of IDO-KO mice injected with α-GalCer, TNF-α secretion in these mice was greater than that in WT mice. Deficiency of IDO exacerbated liver injury in α-GalCer-induced hepatitis. IDO induced by proinflammatory cytokines may decrease the number of TNF-α-producing immune cells in the liver. Thus, IDO may suppress overactive immune response in the α-GalCer-induced hepatitis model.

AB - IDO converts tryptophan to L-kynurenine, and it is noted as a relevant molecule in promoting tolerance and suppressing adaptive immunity. In this study, we examined the effect of IDO in α-galactosylceramide (α-GalCer)-induced hepatitis. The increase in IDO expression in the liver of wild-type (WT) mice administered α-GalCer was confirmed by real-time PCR, Western blotting, and IDO immunohistochemical analysis. The serum alanine aminotransferase levels in IDO-knockout (KO) mice after α-GalCer injection significantly increased compared with those in WT mice. 1-Methyl-D-tryptophan also exacerbated liver injury in this murine hepatitis model. In α-GalCer-induced hepatitis models, TNF-α is critical in the development of liver injury. The mRNA expression and protein level of TNF-α in the liver from IDO-KO mice were more enhanced compared with those in WT mice. The phenotypes of intrahepatic lymphocytes from WT mice and IDO-KO mice treated with α-GalCer were analyzed by flow cytometry, and the numbers of CD49b+ and CD11b+ cells were found to have increased in IDO-KO mice. Moreover, as a result of the increase in the number of NK cells and macrophages in the liver of IDO-KO mice injected with α-GalCer, TNF-α secretion in these mice was greater than that in WT mice. Deficiency of IDO exacerbated liver injury in α-GalCer-induced hepatitis. IDO induced by proinflammatory cytokines may decrease the number of TNF-α-producing immune cells in the liver. Thus, IDO may suppress overactive immune response in the α-GalCer-induced hepatitis model.

UR - http://www.scopus.com/inward/record.url?scp=78049522618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049522618&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.0904173

DO - 10.4049/jimmunol.0904173

M3 - Article

C2 - 20844202

AN - SCOPUS:78049522618

VL - 185

SP - 4554

EP - 4560

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 8

ER -